Weibang Zhendian Closes Nearly RMB 100 Million Series B Led by Dalton Venture to Advance Commercialization in Industrial Inspection, Clinical, and AI for Science | Dalton Venture News
Recently, **Zhejiang Weibang Zhendian Optoelectronic Technology Co., Ltd. (hereinafter: Weibang Zhendian) completed a nearly RMB 100 million Series B round, led by Dalton Venture with participation from IDG Capital**. The funds will primarily be used to advance the commercialization of its products in industrial inspection, clinical applications, AI for Science, and other fields. Prior to this, Weibang Zhendian had completed two funding rounds, with investors including Tao Capital, FreeS Fund, Founder Hesheng, Naton Capital, and SND Group.
Background
Background
Recently, Zhejiang Vibronix Optoelectronics Technology Co., Ltd. (hereafter: Vibronix) completed a Series B financing round of nearly RMB 100 million, led by Dalton Venture with participation from IDG Capital. The funds will primarily be used to advance the commercialization of its products in industrial inspection, clinical applications, AI for Science, and other fields. Prior to this, Vibronix had completed two earlier rounds, with investors including Tao Capital, FreeS Fund, Founder Hesheng, Naton Capital, SND Financial Holdings, and other well-known institutions and individuals.
Founded in 2017, Vibronix is a high-tech enterprise focused on innovation in molecular vibrational spectroscopy, dedicated to building high-end domestically produced spectral analysis and imaging products. Deeply rooted in nonlinear optics, the company's core team brings years of R&D experience in spectroscopy, optical imaging, and optoelectronic analysis. Leveraging its three self-developed spectroscopy platforms — coherent Raman, transient absorption, and pulsed laser infrared — Vibronix has significantly improved core performance metrics such as specificity, sensitivity, resolution, and imaging speed, giving it strong potential to replace existing imported solutions and expand into emerging application scenarios.
Image provided by the company
With the explosive growth of AI, the convergence of scientific instruments and artificial intelligence has become a new trend. Vibronix is actively exploring the "AI for Science" paradigm, deeply integrating high-quality spectral data with AI algorithms — not only providing tools for traditional research, but also building an intelligent data foundation for frontier fields like drug discovery and materials screening. The company's engineered products now address analysis and imaging needs across life sciences, industrial inspection (quality control for semiconductors and new energy materials), clinical diagnostics, and environmental science. Product sales have entered a period of rapid growth, with deliveries made to dozens of domestic and international research institutions and enterprises, including Peking University, the University of Vienna, Zhejiang University, Lanzhou University, and the Shenzhen Institutes of Advanced Technology. This progress has propelled domestically made high-end spectroscopy instruments from lab validation toward large-scale commercialization, and from breaking into the domestic market toward a global footprint.
Dr. Wang Pu, CEO of Vibronix, said: "We thank Dalton Venture and IDG Capital for their trust and support, and all of our existing shareholders for their continued partnership. This round of financing will help Vibronix achieve a commercial leap across three directions: industrial inspection, clinical applications, and AI for Science. We will continue to drive innovation in fundamental spectroscopy technology, build more competitive domestically made high-end scientific instruments, empower researchers and industrial customers worldwide, and advance the intelligent transformation of the scientific instruments industry and domestic substitution."
Dalton Venture said: "We have long been bullish on innovation opportunities at the intersection of hard tech and life sciences. Vibronix has mastered globally leading fundamental technologies in spectral analysis and imaging, and has demonstrated outstanding product engineering capabilities. Amid the AI for Science wave, Vibronix's high-dimensional spectral data assets are extremely scarce and strategically valuable. We are very pleased to lead this round and look forward to the company accelerating commercial deployment in industrial and clinical settings, becoming a benchmark enterprise in China's high-end scientific instruments sector."
END
ID: daltonventure
Long press to follow
** Recommended Reading **
